Managing Intrathecal Drug Delivery (ITDD) in Cancer Patients

被引:10
|
作者
Shah, Rajiv [1 ]
Baqai-Stern, Aisha [2 ]
Gulati, Amitabh [2 ]
机构
[1] New York Presbyterian Hosp, Weill Cornell Med Coll, Dept Anesthesiol, New York, NY USA
[2] Mem Sloan Kettering Canc Ctr, Dept Anesthesiol & Crit Care, Board Certified Anesthesiol & Pain Management, M308, New York, NY 10065 USA
关键词
Intrathecal drug delivery; Intrathecal medications; Cancer pain; Neuraxial trial; CHRONIC PAIN; MANAGEMENT; RECOMMENDATIONS; SELECTION; THERAPY; SYSTEM; IMPACT;
D O I
10.1007/s11916-015-0488-x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Pain is a commonly reported symptom in cancer patients. Patients with cancer pain often fail conservative medical management or have significant side effects to systemic medications. The implantation of an intrathecal drug delivery (ITDD) system may be the most effective treatment option for these patients and can improve their quality of life. This article aims to discuss the choice of intrathecal medications for patients suffering from intractable cancer pain, the management of ITDD throughout a patient's disease course, and the management of complications related to the ITDD system and intrathecal medications.
引用
收藏
页数:5
相关论文
共 50 条
  • [31] Intrathecal Pumps for Managing Cancer Pain
    Textor, Laura Hanssen
    AMERICAN JOURNAL OF NURSING, 2016, 116 (05) : 36 - 44
  • [32] Intrathecal Drug Delivery for the Treatment of Cancer-Associated Chronic Pain in Children
    Kenfield, Meaghan
    Zacharias, Nicholas
    Abd-Elsayed, Alaa
    NEUROMODULATION, 2021, 26 (06): : 1153 - 1163
  • [33] Management of a Cancer Patient with an Intrathecal Drug Delivery System and an Acute Brain Abscess
    Walega, David R.
    Korn, Marc
    JOURNAL OF PALLIATIVE MEDICINE, 2018, 21 (05) : 727 - 729
  • [34] Intrathecal Drug Delivery System (IDDS) for Cancer Pain Management: A Review and Updates
    Upadhyay, Surjya Prasad
    Mallick, Piyush N.
    AMERICAN JOURNAL OF HOSPICE & PALLIATIVE MEDICINE, 2012, 29 (05): : 388 - 398
  • [35] Management of Refractory Cancer Pain with Intrathecal Drug Delivery and Spinal Cord Stimulation
    Bulat, Evgeny
    Crowther, Jason E.
    Chakravarthy, Vikram
    Laufer, Ilya
    Barzilai, Ori
    Gulati, Amitabh
    PALLIATIVE MEDICINE REPORTS, 2024, 5 (01): : 301 - 305
  • [36] Intrathecal drug delivery systems for cancer pain: Considerations for device type and indication
    Mukhdomi, Taif
    Andrassy, Bennett
    Mukhdomi, Junaid
    PAIN PRACTICE, 2024, 24 (06) : 873 - 874
  • [37] Efficacy of intrathecal drug delivery system for refractory cancer pain patients: A single tertiary medical center experience
    Lin, Chih-Peng
    Lin, Wen-Ying
    Lin, Feng-Sheng
    Lee, Yow-Shan
    Jeng, Chuen-Shin
    Sun, Wei-Zen
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2012, 111 (05) : 253 - 257
  • [38] Programmable morphine pump (an intrathecal drug delivery system) - A promising option for pain relief and palliation in cancer patients
    Singh, Manish
    Cugati, Goutham
    Singh, Pratibha
    Singh, Ajai Kumar
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2012, 33 (01) : 58 - +
  • [39] Complications associated with intrathecal drug delivery systems
    Delhaas, E. M.
    Huygen, F. J. P. M.
    BJA EDUCATION, 2020, 20 (02) : 51 - 57
  • [40] Pump IT Up-Perioperative Care of Patients With Intrathecal Drug Delivery Systems
    Nelson, Ariana M.
    Jericho, Barbara G.
    Anitescu, Magdalena
    ANESTHESIA AND ANALGESIA, 2022, 134 (01): : 32 - 34